US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (CB2) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cannabinoid Receptor Type 2 (CB2) Agonists Report helps to identify emerging players ...  |  read more...
USD 1,250
Bipolar Disorder (Manic Depression)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bipolar Disorder (Manic Depression) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Brain Injury-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Injury Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Injury- Pipeline ...  |  read more...
USD 1,250
Brain Tumor-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Tumor Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Tumor- Pipeline ...  |  read more...
USD 1,250
Cluster Headache Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cluster Headache Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Cognitive Disorders-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cognitive Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Cognitive Disorders- Pipeline ...  |  read more...
USD 1,250
Diabetic Peripheral Neuropathy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Diabetic Peripheral Neuropathy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Generalized Seizures-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Generalized Seizures Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Generalized Seizures- Pipeline ...  |  read more...
USD 1,250
Guillain-Barre Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Guillain-Barre Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Guillain-Barre Syndrome- Pipeline ...  |  read more...
USD 1,250
Memory Impairment-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Memory Impairment Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Memory Impairment- Pipeline ...  |  read more...
USD 1,250
Mild Cognitive Impairment-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mild Cognitive Impairment Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Narcolepsy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Narcolepsy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Narcolepsy- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Panic Disorders-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Panic Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Panic Disorders- Pipeline ...  |  read more...
USD 1,250
Post-Traumatic Stress Disorder (PTSD)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post-Traumatic Stress Disorder (PTSD) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Psychosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Psychosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Psychosis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Recurrent Malignant Glioma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Recurrent Malignant Glioma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Tourette Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Tourette Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Tourette Syndrome- Pipeline ...  |  read more...
USD 1,250
Traumatic Brain Injury-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Traumatic Brain Injury Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Treatment Resistant Depression-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Treatment Resistant Depression Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015
3/19/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
2015 U.S. Patient care - Nervous system & sense organ disorders sold through Offices of physicians-Product & Services Report
5/15/2015 | published by: Barnes Reports
... demographics. The report features 2015 current and 2016 forecast estimates on the sales of Patient care - Nervous system & sense organ disorders sold through Offices of physicians nationally and for all 50 U.S. States ...  |  read more...
USD 199
The 2016-2021 World Outlook for Anti-Migraine Drugs
4/6/2015 | published by: Icon Group International, Inc.
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly ...  |  read more...
USD 995
The 2016-2021 World Outlook for Bipolar Disorder Drugs
4/6/2015 | published by: Icon Group International, Inc.
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader ...  |  read more...
USD 995
The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting ...  |  read more...
USD 995
General Anxiety Disorder - Pipeline Review, H1 2015
4/15/2015 | published by: Global Markets Direct
... information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10